Early Career Investigator Workshop (2023)
PROGRAM DESCRIPTION: Nurturing the success of early-career urologist-scientists is a major goal of the AUA Office of Research and the AUA Research Council. In particular, when the skills needed to be successful in research are well-developed in urology physician-scientists (researchers), they have enhanced abilities to more effectively communicate with their patients on the latest research relevant to the patients’ diseases or conditions, engender greater patient confidence in evidence-based clinical decision-making, and better ensure delivery of the highest quality of patient care through the ability to understand, engage in, and employ in their practice new knowledge from urologic research. The ability to successfully compete for funding for a physician’s own research program is an integral part of the skillset needed to be successful in research. The collaborative Early-Career Investigators Workshop (ECIW) provides an opportunity for promising junior researchers to receive individualized mentoring, insights into the scientific review process, information about independent funding sources, and grant writing guidance. The goal of the workshop is to motivate and support researchers in the early stages of their careers by providing an outstanding program led by established, well-funded investigators (both researchers and other investigators) in urologic research. This 2.5-day workshop and its activities are geared for individuals planning to submit competitive research proposals to the major funders of urologic research.
CURRICULUM The workshop agenda fosters research career success by providing participants with a solid foundation for successful grant writing.
The workshop and activities include interaction with senior scientific advisors in small group and individual sessions. The program consists of five major components:
- Didactic Instruction
- Individual Proposal Review and Critique
- Grant Review/Revision
- Mock Study Section
- Funding Speaker Webinar
The purpose of this workshop is to educate urologists working in urologic research on skills needed to be successful in research, which will, in turn, enhance their abilities to more effectively communicate with their patients on the latest research relevant to the patients’ diseases or conditions, engender greater patient confidence in evidence-based clinical decision-making, and better ensure delivery of the highest quality of patient care through the ability to understand, engage in, and employ in their practice new knowledge from urologic research. The research skill of focus for this meeting is successful grant writing. The education will be achieved through classroom-style presentations and interactions with senior investigators serving as scientific advisors. Participating scientific advisors will be chosen based on their successful history of funding in urologic research and track record of training pre-doctoral and post-doctoral researchers.
At the conclusion of the workshop, participating researchers will be able to:
- Describe the cutting-edge and developing areas in basic and translational research, and identify components of their research efforts that intersect with or expand upon these;
- Develop and refine a compelling, innovative, and testable hypothesis;
- Develop a reasonable and ‘do-able’ experimental plan that adequately tests the stated hypothesis;
- Identify potential limitations of the proposed experimental plan and alternative experimental outcomes, and develop responsive alternative experimental approaches
- Expand the initial concepts presented in the application to optimally project future directions, concepts, and studies
- Avoid common pitfalls that typically dampen the enthusiasm of grant reviewers; and
- Describe the necessary administrative (nuts-and-bolts) components of NIH grant applications.
Funding for this conference was made possible (in part) by 1 R13 DK137583-01 from NIDDK. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
COI Work Group Disclosures
Planner & Faculty Disclosures
|Adam, Rosalyn M.||No relevant financial relationships|
|Anger, Jennifer T.||No relevant financial relationships|
|Barbieri, Christopher E.||No relevant financial relationships|
|Boulanger-Espeut, Corinne||No relevant financial relationships|
|Damaser, Margot||No relevant financial relationships|
|Elena, Joanne||No relevant financial relationships|
|Flannigan, Ryan K||No relevant financial relationships|
|Gorin, Michael A.||No relevant financial relationships|
|Hughes Jr., Francis||No relevant financial relationships|
|Hung, Andrew||No relevant financial relationships|
|Lamb, Dolores Jean||No relevant financial relationships|
|McGhee, Nora||No relevant financial relationships|
|Miller, Theresa||No relevant financial relationships|
|Penniston, Kristina L.||No relevant financial relationships|
|Ramasamy, Ranjith||No relevant financial relationships|
|Rankin, Tracy||No relevant financial relationships|
|Salive, Marcel||No relevant financial relationships|
|Schwinder, Eric Jay||No relevant financial relationships|
|Stewart, Lamonica Vanette||No relevant financial relationships|
|Taymans, Susan||No relevant financial relationships|
|Zderic, Stephen Anthony||No relevant financial relationships|
AUA Staff have nothing to disclose.
All relevant financial relationships have been mitigated.
AUA ACCREDITATION INFORMATION
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Urological Association (AUA) designates this Other activity (live activities and enduring materials) for a maximum of 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
MITIGATION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:
- Peer review for valid, evidence-based content by the AUA COI Review Work Group.
- Attestation that clinical recommendations are evidence-based and free of commercial bias.
- Introduction of a debate format (point-counterpoint)
- Inclusion of moderated panel discussion with unbiased moderator
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Divestiture of the relationship by faculty
- Recusal from controlling relevant aspects of planning
- Selection of alternative faculty for specific topic
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
- 14.25 AMA PRA Category 1 Credit™
- 14.25 Non-Physician Participation